References Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (transcend-T2D-1): A double-blind, randomised, phase 3 trial - the Lancet
Ozempic (semaglutide) is an injectable anti-diabetic medication that improves blood sugar control and promotes weight loss by acting on appetite-regulating pathways in the brain
Increased daily movement through non-exercise activity thermogenesistaking stairs, parking farther away, standing desksalso contributes meaningfully to energy expenditure
When it comes to brain power, greens should be on your plate (and cover a lot of that plate) every meal
How long do palpitations on semaglutide last
He also recommends screening for genetic Lipoprotein(a), a time bomb invisible on standard lipid panels